Five Lives offers a suite of digital therapeutic products, including Five Lives Brain Health for prevention and Five Lives Care, launched in early 2026, as a therapeutic solution for mild cognitive impairment. The platforms deliver over 500 adapted physical activity videos, cognitive games, language exercises, and personalized lifestyle recommendations with real-time difficulty adjustment. A randomized clinical trial of 180 participants across seven hospitals in the UK and France showed statistically significant improvements in executive function and quality of life after three months of use. The Care app is priced at €30 per month and has received recommendations from neurologists and geriatricians at leading French and British institutions. The company is pursuing reimbursement via France's PECAN digital therapy program with a target of 2027 and plans to integrate AI to further personalize sessions. Early traction includes 200,000 cumulative downloads and 5,000 active patients on the therapeutic app within two months, and Five Lives projects revenues of €400,000 in 2025, €1 million in 2026, and €5–10 million in 2027 upon reimbursement.

Total raised

$6M

Funding rounds

2

Latest round

Series A

Latest activity

Apr 2026